Skip to main content
GutCited

Amyloid-β-driven Alzheimer's disease reshapes the colonic immune system in mice.

Priya Makhijani, Taylor R Valentino, Max Manwaring-Mueller, Rohini Emani, Wei-Chieh Mu et al.
Other Cell reports 2025 1 citations

Study Design

Study Type
Other
Population
5XFAD amyloid-beta mouse model of Alzheimer's
Intervention
Amyloid-β-driven Alzheimer's disease reshapes the colonic immune system in mice.
Comparator
Standard diet (5XFAD mice)
Primary Outcome
Gut IgA+ cells, Treg levels, AD-associated frailty
Effect Direction
Positive
Risk of Bias
Unclear

Abstract

The "gut-brain axis" is an emerging target in Alzheimer's disease (AD), although its immunological features remain poorly understood. Using single-cell RNA sequencing, coupled to extensive spectral-tuning flow cytometry validation of the colon immune compartment in the 5XFAD amyloid-β mouse model, we found several AD-associated changes including in B/plasma cell activity. Notably, levels of CXCR4+ antibody-secreting cells are reduced in 5XFAD colons. This change corresponds with accumulating CXCR4+ B cells and gut-specific IgA+ cells in the brain and dura mater, respectively. Consistently, a chemokine ligand for CXCR4, CXCL12, is expressed at higher levels in the 5XFAD brain and in in silico-analyzed human AD brain studies, supporting altered neuroimmune trafficking. An inulin prebiotic fiber diet could expand gut IgA+ cells, rescue peripheral Treg levels, reduce dysbiosis, improve serum microbial metabolite levels, and attenuate overall AD-associated frailty. Our study reveals key aspects of the gut-brain axis and highlights potential targets against AD.

TL;DR

An inulin prebiotic fiber diet could expand gut IgA+ cells, rescue peripheral Treg levels, reduce dysbiosis, improve serum microbial metabolite levels, and attenuate overall AD-associated frailty.

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.